Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-07

Clinical Trial Update: Intranasal Dexmedetomidine Dose-finding Study [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial of intranasal dexmedetomidine in laceration repair has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Laceration Repair | Phase 2 | Status: COMPLETED